Chief Executive Officer
CEO of GRI’s non-Americas portfolio, Andrew is responsible for GRI in the UK and EMEA and APAC.
An experienced and recognised business leader with a global health and managed service background, Andrew has delivered the successful integration of numerous merger and acquisition projects including the sale of his own clinical service business to global service provider Serco Group Plc.
Andrew originally started his career in the NHS and over the last twenty plus years has gained extensive experience in the successful growth and development of FTSE 100 companies, PLCs, private equity backed and private organisations.
Andrew joined, what was known as, de Poel health+care in 2013 as Managing Director. He subsequently assumed MD responsibility for de Poel’s newly formed education business and business development across the group. In 2015 Andrew was appointed as Group Managing Director, with responsibility for the strategic development and operations of the entire de Poel group. Following an MBO led by Andrew in September 2016, he was appointed as CEO of the de Poel group. Andrew subsequently led the de Poel team in the acquisition by GRI and was appointed CEO of the non-Americas business.
Andrew is a recognised leader, winning Finance Monthly’s CEO of the Year Award in 2018 for a second consecutive year and the ACQ5 award for the Game Changer of 2017, in addition to featuring as one of the Top 100 most influential leaders in Europe by Staffing Industry Analysts. Andrew’s thought leadership has been published by Bloomsbury Professional as part of ‘Doing Business After Brexit: A Practical Guide to the Legal Changes’ ISBN 9781784519360.